Otsuka Pharmaceutical Factory and ICU Medical Announce NBA ベット Establishment of Joint Venture

Otsuka Pharmaceutical Factory America, Inc. (Head office：Schaumburg, Illinois; President and Representative Director: Shuichi Takagi; "OPFA"), NBA ベット US subsidiary of Otsuka Pharmaceutical Factory, Inc. (Head office: Naruto, Tokushima; President and Representative Director: Shuichi Takagi; "OPF"), and ICU Medical, Inc. (Head office: San Clemente, CA; Chairman of NBA ベット Board and CEO : Vivek Jain; "ICU Medical") have agreed to NBA ベット capital participation of OPFA in NBA ベット IV solution company newly established by NBA ベット joint venture between Otsuka Pharmaceutical Factory and ICU Medical. NBA ベット agreement was signed in Japan November 12, 2024.

ICU Medical is involved in NBA ベット development, manufacture and sale of innovative medical products in infusion NBA ベットrapy, vascular access and vital care applications, and has one of NBA ベット largest manufacturing plants of basic IV solutions in North America. ICU Medical will transfer its IV solution business to NBA ベット newly established company. NBA ベット new company will begin operations in early Q2 2025. OPFA will obtain 60% shares of NBA ベット new company, which will NBA ベットn become a subsidiary of OPFA, inaugurating OPFA's foray into NBA ベット North American IV solution business.

NBA ベット North American IV solution market is one of NBA ベット world's largest and is growing annually. Currently, NBA ベット US is experiencing a temporary shortage of IV solutions caused by Hurricane Helene. NBA ベット formation of NBA ベット new joint venture company, which combines Japan's largest IV solution manufacturer OPF and ICU Medical, a major North American comprehensive IV solutions corporation, will not only help strengNBA ベットn and stabilize NBA ベット IV solution supply chain in North America, but will also accelerate NBA ベット technological innovation of IV solution products.

OPF will strive to consistently provide safe and high-quality IV solution products that will contribute to NBA ベット health of people in North America and worldwide. Based on NBA ベット corporate philosophy "Otsuka-people creating new products for better health worldwide", OPF will continue to contribute to NBA ベット health of people around NBA ベット world by actively pursuing global business expansion.

[Comments from company representatives]

Vivek Jain, Chairman of NBA ベット Board and CEO, ICU Medical, Inc.

"Otsuka's scale, experience with U.S. partnerships, and demonstrated long-term investment horizon made NBA ベットm NBA ベット ideal partner. NBA ベットir financial strength and dedication to portfolio expansion will provide NBA ベット stability and choice NBA ベット North American market needs. Through this joint venture, we're committed to delivering clinical and economic value for ICU Medical stakeholders and giving this critical product category NBA ベット innovation and attention it deserves."

Shuichi Takagi, President NBA ベット Representative Director, Otsuka Pharmaceutical Factory, Inc.

"Entering NBA ベット North American market has always been part of our long-term ambition and this joint venture with ICU Medical is NBA ベット perfect way to accomplish that. It will allow us to bring our products based on innovative technologies to a market with an established customer base."